Evidence map›Paper›PMID 38612759›Full record

ArticleInternational journal of molecular sciences2024

Effect of TRPV4 Antagonist GSK2798745 on Chlorine Gas-Induced Acute Lung Injury in a Swine Model.

Meghan S Vermillion, Nathan Saari, Mathieu Bray, Andrew M Nelson, Robert L Bullard, Karin Rudolph, Andrew P Gigliotti, Jeffrey Brendler, Jacob Jantzi, Philip J Kuehl and 5 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. TRPV4 Channel Modulators as Potential Drug Candidates for Cystic Fibrosis.International journal of molecular sciences · 2024
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Meghan S VermillionLovelace Biomedical Research Institute, Albuquerque, NM 87108, USA.
Nathan SaariLovelace Biomedical Research Institute, Albuquerque, NM 87108, USA.
Mathieu BrayGSK, Collegeville, PA 19426, USA.
Andrew M NelsonLovelace Biomedical Research Institute, Albuquerque, NM 87108, USA.
Robert L BullardLovelace Biomedical Research Institute, Albuquerque, NM 87108, USA.
Karin RudolphLovelace Biomedical Research Institute, Albuquerque, NM 87108, USA.
Andrew P GigliottiLovelace Biomedical Research Institute, Albuquerque, NM 87108, USA.
Jeffrey BrendlerLovelace Biomedical Research Institute, Albuquerque, NM 87108, USA.
Jacob JantziLovelace Biomedical Research Institute, Albuquerque, NM 87108, USA.
Philip J KuehlLovelace Biomedical Research Institute, Albuquerque, NM 87108, USA.ORCID 0000-0002-7567-3002
Jacob D McDonaldLovelace Biomedical Research Institute, Albuquerque, NM 87108, USA.
Mark E BurgertGSK, Collegeville, PA 19426, USA.
Waylon WeberLovelace Biomedical Research Institute, Albuquerque, NM 87108, USA.
Scott SucoloskiGSK, Collegeville, PA 19426, USA.
David J BehmGSK, Collegeville, PA 19426, USA.
Lovelace Respiratory Research Institute · USGlaxoSmithKline (United States) · US

Funding

Biomedical Advanced Research and Development Authority HHSO100201700009C/75A50122F61001
6 · The paper itself

Abstract

As a regulator of alveolo-capillary barrier integrity, Transient Receptor Potential Vanilloid 4 (TRPV4) antagonism represents a promising strategy for reducing pulmonary edema secondary to chemical inhalation. In an experimental model of acute lung injury induced by exposure of anesthetized swine to chlorine gas by mechanical ventilation, the dose-dependent effects of TRPV4 inhibitor GSK2798745 were evaluated. Pulmonary function and oxygenation were measured hourly; airway responsiveness, wet-to-dry lung weight ratios, airway inflammation, and histopathology were assessed 24 h post-exposure. Exposure to 240 parts per million (ppm) chlorine gas for ≥50 min resulted in acute lung injury characterized by sustained changes in the ratio of partial pressure of oxygen in arterial blood to the fraction of inspiratory oxygen concentration (PaO

Indexed as

Acute Lung InjuryAntineoplastic AgentsBenzimidazolesSpiro CompoundsAnimalsChlorineInflammationOxygenSwineTRPV Cation ChannelsAntineoplastic AgentsBenzimidazolesChlorineGSK2798745OxygenSpiro CompoundsTRPV Cation Channelsacute lung injury (ALI)acute respiratory distress syndrome (ARDS)mechanical ventilationpulmonary edematransient receptor potential vanilloid 4

Identifiers

PMID38612759
PMCPMC11011849
OpenAlexW4393523809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.